Julie Harper, MD, talks about the Epsolay drug approval that happened April 25. She dives into its mechanism of action, its potential as both a first line treatment or combination therapy, and what she would like to see next in its research.
Gina Mangin, PA-C, and James Treat, MD, dive into the intricacies of acne and rosacea, going beyond the surface of both skin conditions and giving important treatment tips at the 2022 New Wave Dermatology Conference.
Sol-Gel Technologies and Galderma announce the FDA approval of the 5% benzoyl peroxide, cream for the treatment of inflammatory lesions of rosacea.
Dermatology Times® interviews editorial board member Richard Gallo, MD, PhD, who dives into what is currently lacking is rosacea patient care, how the new mechanisms of action of these potential treatments will better address current struggles, and more.
A study in the Journal of Clinical and Aesthetic Dermatology dove into the hereditary predisposition of rosacea within families.
Patients suffering from several dermatologic diseases and conditions including acne, rosacea, and pruritus can largely benefit from the new and exciting therapies and treatment modalities that have recently become available.
Treating these patients can be a challenge, but it can also be ‘as easy as pie’ if you follow these tips.
Hilary Baldwin, MD, used examples of challenging cases to show how to develop successful combination regimens.
Neal Bhatia, MD, highlights new approaches in rosacea therapy in his session at the Fall Clinical Dermatology Conference for PAs & NPs.
Optimizing rosacea treatment outcomes isn’t only about papules and pustules. Facial erythema needs to be part of an effective management plan.